Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

Improving Variant Prioritization in Exome Analysis by Entropy-Weighted Ensemble of Multiple Tools.

A Robust Phenotype-Driven Likelihood Ratio Analysis Approach Assisting Interpretable Clinical Diagnosis of Rare Diseases.

Prioritization of Nonsynonymous Single Nucleotide Variants for Exome Sequencing Studies Via Integrative Learning on Multiple Genomic Data

Leveraging Multiple Genomic Data to Prioritize Disease-Causing Indels from Exome Sequencing Data

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab

Prioritization of oligogenic variant combinations in whole exomes

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

A Comprehensive Framework for Prioritizing Variants in Exome Sequencing Studies of Mendelian Diseases

REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Laboratory.

Extraction of Sequence Conservation Features for the Prioritization of Candidate Single Amino Acid Polymorphisms

An Initial Survey of the Performances of Exome Variant Analysis and Clinical Reporting among Diagnostic Laboratories in China

Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

Enhancing Clinical Applications by Evaluation of Sensitivity and Specificity in Whole Exome Sequencing

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases

Integrating Multiple Genomic Data to Predict Disease-Causing Nonsynonymous Single Nucleotide Variants in Exome Sequencing Studies

Missing genetic diversity impacts variant prioritisation for rare disorders

Improving Somatic Variant Identification Through Integration of Genome and Exome Data.

The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China